Drugs / ProRoot (Aggregate)
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03395496 | May 2013 → May 2016 | dental caries, dental pulp disorder | Istanbul University | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03135626 | Mar 2013 → Jan 2014 | dental caries | Istanbul University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ProRoot (Aggregate) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03135626 ↗ |
| Modality | Other / unclassified | “two different mineral trioxide aggregate (MTA) products (white ProRoot® MTA and MTA Plus®)” NCT03135626 ↗ |